Evoke Pharma (EVOK) Tops Q3 EPS by 12c

Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.42), $0.12 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist